Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

REVIUM Rx. (RVRC) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

REVIUM Rx. (RVRC), most recent 12 months reported: net loss $13.45M. Latest balance sheet on file: liquid cash $842K, total debt $1K, net cash $841K. From SEC filings. Others in Pharmaceutical Preparations: RELMADA THERAPEUTICS, INC. · TRANSCODE THERAPEUTICS, INC. · Rein Therapeutics, Inc. · Reviva Pharmaceuticals Holdings, Inc. · Rezolute, Inc. · Sagimet Biosciences Inc. · SHUTTLE PHARMACEUTICALS HOLDINGS, INC. · SIONNA THERAPEUTICS, INC.

Stock screener

Watchlist